Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions-Reference-Cited by-同舟云学术

Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions

Published:2014-05-20 Issue:4 Volume:220 Page:2289-2301
ISSN:1863-2653
Container-title:Brain Structure and Function
language:en
Short-container-title:Brain Struct Funct

Author:

Narváez Manuel,Millón Carmelo,Borroto-Escuela Dasiel,Flores-Burgess Antonio,Santín Luis,Parrado Concepción,Gago Belén,Puigcerver Araceli,Fuxe Kjell,Narváez José Angel,Díaz-Cabiale Zaida

Publisher

Springer Science and Business Media LLC

Subject

Histology,General Neuroscience,Anatomy

Link

http://link.springer.com/content/pdf/10.1007/s00429-014-0788-7.pdf

Reference41 articles.

1. AbdAlla S, Abdel-Baset A, Lother H, el Massiery A, Quitterer U (2005) Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. J Mol Neurosci 26(2–3):185–192. doi: 10.1385/JMN:26:2-3:185

2. Bailey KR, Pavlova MN, Rohde AD, Hohmann JG, Crawley JN (2007) Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze. Pharmacol Biochem Behav 86(1):8–20. doi: 10.1016/j.pbb.2006.11.024

3. Barrera G, Echevarria DJ, Poulin JF, Laforest S, Drolet G, Morilak DA (2005) One for all or one for one: does co-transmission unify the concept of a brain galanin “system” or clarify any consistent role in anxiety? Neuropeptides 39(3):289–292. doi: 10.1016/j.npep.2004.12.008

4. Bing O, Moller C, Engel JA, Soderpalm B, Heilig M (1993) Anxiolytic-like action of centrally administered galanin. Neurosci Lett 164(1–2):17–20 0304-3940(93)90846-D

5. Blackshear A, Yamamoto M, Anderson BJ, Holmes PV, Lundstrom L, Langel U, Robinson JK (2007) Intracerebroventricular administration of galanin or galanin receptor subtype 1 agonist M617 induces c-Fos activation in central amygdala and dorsomedial hypothalamus. Peptides 28(5):1120–1124. doi: 10.1016/j.peptides.2007.01.015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Cognitive Functions and Neuronal Growth through NPY1R Agonist and Ketamine Co-Administration: Evidence for NPY1R-TrkB Heteroreceptor Complexes in Rats;Cells;2024-04-12

2. Long‐term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co‐administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus;The FASEB Journal;2024-04-04

3. Enhanced neuronal survival and BDNF elevation via long-term co-activation of galanin 2 (GALR2) and neuropeptide Y1 receptors (NPY1R): potential therapeutic targets for major depressive disorder;Expert Opinion on Therapeutic Targets;2024-04-02

4. Potentiation of antidepressant effects: NPY1R agonist and ketamine synergy enhances TrkB signaling and neurogenesis in the ventral hippocampus;Expert Opinion on Therapeutic Targets;2024-04-02

5. Enhancement of neurogenesis and cognition through intranasal co-delivery of galanin receptor 2 (GALR2) and neuropeptide Y receptor 1 (NPY1R) agonists: a potential pharmacological strategy for cognitive dysfunctions;Behavioral and Brain Functions;2024-03-28